Abortion Threatened Clinical Trial
Official title:
Biochemical Versus Ultrasound Findings as Predictors of Fetal Loss in Cases of First Trimester Threatened Miscarriage
Threatened miscarriage occurs in about one-fifth of pregnancies with an estimated miscarriage
rate of 3-16% after successful demonstration of fetal cardiac activity. Various biochemical
markers have been studied previously to predict the outcome of threatened miscarriage;
However, the results have been conflicting. Several studies have documented that a slow
embryonic heart rate at 6.0-7.0 Weeks' gestation is associated with a high rate of first
trimester fetal demise.
our aim: To evaluate the accuracy of ultrasound findings in comparison to serum CA125 and
progesterone in predicting fetal demise in cases of first trimester threatened miscarriage.
Will this pregnancy be continued after the first trimester or not?
Status | Recruiting |
Enrollment | 42 |
Est. completion date | September 30, 2019 |
Est. primary completion date | May 31, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Singleton Pregnancy. - Age20-35years. - Gestational age between6 to 8weeks. - Threatened miscarriage is diagnosed by vaginal bleeding, closed cervix and positive fetal life. - Patients who are sure of their dates (three regular menstrual cycles before conception without the use of hormonal contraception. Exclusion Criteria: Patients with recurrent miscarriage or pregnancy of unknown location (PUL). - Patients had ovulation induction medications or on progesterone treatment. - Patients with past medical history of diabetes mellitus or chronic hypertension. - Patients who are unsure of the last menstrual period date or with irregular menstrual cycle. - Pregnancy associated with presence of ovarian cyst. - Molar pregnancy. - Those who had a history of maternal disease which would cause an increase in CA-125level. These diseases include chronic pelvic infection, endometriosis, myoma uteri, endometrioma and lung, kidney and hepatic diseases. |
Country | Name | City | State |
---|---|---|---|
Egypt | Ain Shams University | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ultra sound | presence of fetal heart rate | the 12th week of gestation |